LINC01133 could promote the malignant behaviors in several tumor, such as lung adenocarcinoma [28], hepatocellular carcinoma [29], triple-negative breast cancer [30] and nasopharyngeal carcinoma [31]. This evidence concerns the gene LINC01133 and hepatocellular carcinoma.